In a time of declining margins on the delivery of health care and diminishing federal grant funding for basic research,
academic institutions are turning en masse to diversification efforts as a means to sustain financial resources. A primary focus
of diversification, and one found at nearly all academic institutions, is technology
transfer. Although called by many names, technology transfer is the process of moving
the intellectual capital of an institution, whether new medical devices, new drugs,
or the expertise of its faculty, into the public sector, altruistically for the benefit
of patients and realistically, for the financial benefit of investors, the academic
institution, and often the physician-inventor. The financial return to academia from
technology transfer activities is significant. In 2005, the most recent year for which
full data are available, technology transfer offices in the United States signed nearly
5000 new licenses and generated nearly $1.5 billion dollars through the commercialization
of intellectual property
.
1
The Association of University Technology Managers. Available online at http://www.autm.net. Accessed June 2007.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Reference
The Association of University Technology Managers. Available online at http://www.autm.net. Accessed June 2007.
Article info
Publication history
Accepted:
November 5,
2007
Identification
Copyright
© 2008 Mosby, Inc. Published by Elsevier Inc. All rights reserved.
